Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB

Completed

Conditions studied: Bladder Cancer

In brief

The study is intended to investigate whether the improved initial detection and resection of bladder cancer lesions in patients with non-muscle invasive bladder cancer with Hexvix (Cysview) fluorescence cystoscopy/TURB will lead to a longer-term reduction in recurrences compared to standard white light cystoscopy/TURB.

Key facts

Study ID

NCT01166230

Run by

Photocure

People needed

551

Starts

2010-06-01

Expected to finish

2010-12-01

Last updated by the study team

2019-04-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients of study PC B305/04 with Ta or T1, that were followed for recurrence are eligible to be included in this study.

You may not qualify if…

• Patient died during clinical study PC B305/04

Where it is running

• Stanford Cancer Center, Department of Urology — Stanford, California, United States
• V.A. Medical Center — Gainesville, Florida, United States
• University of Miami School of Medicine — Miami, Florida, United States
• South Florida Clinical Research Center, Inc. — Pembroke Pines, Florida, United States
• The Emory Clinic, Dept of Urology — Atlanta, Georgia, United States
• Boston University School of Medicine — Boston, Massachusetts, United States
• Urologic Clinical Research Unit, Gonda 7102, Mayo Clinic Rochester — Rochester, Minnesota, United States
• Hackensack University Medical Center — Hackensack, New Jersey, United States
• Mount Sinai Medical Center, Department of Urology — New York, New York, United States
• URMC — Rochester, New York, United States
• Thomas Jefferson Medical College, Department of Neurology — Philadelphia, Pennsylvania, United States
• Vanderbilt University Medical Center, Department of Urologic Surgery — Nashville, Tennessee, United States
• Baylor College of Medicine, Scott Department of Urology — Houston, Texas, United States
• The University of Texas MD Anderson cancer center — Houston, Texas, United States
• AKH, Klinik für Urologie der Universität Wien — Vienna, Austria
• Kingston General Hospital — Kingston, Ontario, Canada
• CHUQ Hotel-Dieu de Quebec — Québec, Canada
• University Clinic of Giessen, Department of Urology — Giessen, Germany
• Klinikum der Universität München-Großhardern, Urologische Klinik und Poliklinik — München, Germany
• Urologische Klinik München-Planegg — Planegg, Germany
• Akadem. Lehrkrankenhaus der Uni Regensburg, Klinik für Urologie — Regensburg, Germany
• Universitätsklinik Tuebingen, Universitätsklinik für Urologie — Tübingen, Germany
• Department of Urology, Academic Medical Center, University of Amsterdam — Amsterdam, Netherlands
• Department of Urology, UMC St. Radboud — Nijmegen, Netherlands

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.